(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 200.4MM | +9% |
Gross Profit | 136.6MM | +14% |
Cost Of Revenue | 63.8MM | -1% |
Operating Income | -18.3MM | -25% |
Operating Expenses | 154.9MM | - |
Net Income | -22.2MM | -23% |
R&D | 18.9MM | +2% |
G&A | 34.5MM | +27% |
Marketing | 97.7MM | +3% |
Amortization | 14MM | +7% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.
LEWISVILLE, Texas, April 23, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 a.m. ET the same day.
LEWISVILLE, Texas, April 16, 2024--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer.
LEWISVILLE, Texas, March 18, 2024--Former NuVasive executive joins Orthofix as Chief People and Business Operations Officer.
Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Orthofix Medical Inc (OFIX) released its 8-K filing on March 5, 2024, showcasing a year of substantial growth and operational efficiency
Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript March 5, 2024 Orthofix Medical Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.14. OFIX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Orthofix […]
Q4 2023 Orthofix Medical Inc Earnings Call
LEWISVILLE, Texas, March 05, 2024--Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the fourth quarter and year ended December 31, 2023, and issued guidance for the full year 2024.
LEWISVILLE, Texas, February 29, 2024--Orthofix realigns its Spine business unit and appoints Jason Shallenberger to President of the Bone Growth Therapies business.